Insights
Deal Insights
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
Learn More
Deal Insights
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
Learn More
BlueBook
Diagnostics and Tools March 2024
Highlights from this edition: Invicro, LLC was acquired by Calyx Services Inc., Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ARTMS, INC., Zephyr AI, Inc. closed a $111.4MM Series A Financing, led by Eli Lilly and, Revolution Growth, EPIQ Capital Group, LLC
Download Now
BlueBook
Pharma Services March 2024
Highlights from this edition: Endpoint Clinical and Patient Access Businesses of Fortrea was acquired by Arsenal Capital Partners, Calyx Services Inc. announced its acquisition of Invicro, LLC, Flosonics Medical closed a $20MM Series A Financing, led by Genesys Capital Partners Inc., Arboretum Ventures LLC, New Leaf Venture Partners, LLC, iGan Partners
Download Now
Deal Insights
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
Learn More
BlueBook
Diagnostics and Tools February 2024
Highlights from this edition: Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation, Triple Ring Technologies received funding from 1315 Capital, Renovaro Biosciences Inc. announced its acquisition of Cyclomics
Download Now
/
6
Gain Insight Into The Health
Sciences Industries
Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team.